Stock listing

6990 Stock Price, News, Filings & Events — Sichuan Kelun-biotech Biopharmaceutical Co., Ltd. Class H

Selected listing: 6990 · HKEX · HKD · HK

This page tracks Sichuan Kelun-biotech Biopharmaceutical Co., Ltd. Class H's 6990:HKEX listing on HKEX in HKD for HK, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 6990:HKEX. 6990:HKEX is the stock-level entry point for investors researching Sichuan Kelun-biotech Biopharmaceutical Co., Ltd. Class H, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Sichuan Kelun-biotech Biopharmaceutical Co., Ltd. Class H, trading under the ticker 6990 on the Hong Kong market, has a market capitalization of approximately HKD 16.44 billion. The company focuses on biopharmaceutical development and manufacturing. Its operations are aimed at advancing healthcare solutions through innovative biotechnology.

6990:HKEXHKDHKUpdated September 11, 2026
Sichuan Kelun-biotech Biopharmaceutical Co., Ltd. Class H logo
Ticker
6990:HKEX
Asset type
Stock
Market cap
$14.95B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
HKEX
Currency
HKD

Sichuan Kelun-biotech Biopharmaceutical Co., Ltd. Class H 6990:HKEX stock context

This page tracks Sichuan Kelun-biotech Biopharmaceutical Co., Ltd. Class H's 6990:HKEX listing on HKEX in HKD for HK, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 6990:HKEX. 6990:HKEX is the stock-level entry point for investors researching Sichuan Kelun-biotech Biopharmaceutical Co., Ltd. Class H, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Sichuan Kelun-biotech Biopharmaceutical Co., Ltd. Class H, trading under the ticker 6990 on the Hong Kong market, has a market capitalization of approximately HKD 16.44 billion. The company focuses on biopharmaceutical development and manufacturing. Its operations are aimed at advancing healthcare solutions through innovative biotechnology.

Latest news from Sichuan Kelun-biotech Biopharmaceutical Co., Ltd. Class H

All Sichuan Kelun-biotech Biopharmaceutical Co., Ltd. Class H news →

Research Sichuan Kelun-biotech Biopharmaceutical Co., Ltd. Class H

Alternate listings